Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides

Klik: 346
ID: 119175
2001
PDF Gratis
Metrik Kualitas & Kinerja Artikel
Kualitas Keseluruhan Improving Quality
0.0 /100
Menggabungkan data keterlibatan dengan penilaian kualitas akademik berbasis AI
Penilaian Kualitas AI
Belum dianalisis
Abstrak
We evaluated the impact of applying the Infectious Diseases Society of America guidelines for febrile neutropenic patients in reducing the use of glycopeptides. Forty-five prior episodes of febrile neutropenia were compared to 97 episodes seen after application of the guidelines. Glycopeptide use wa …
Kunci Referensi
m2001infectionapplication Gunakan kunci ini untuk mengutip otomatis dalam naskah saat menggunakan SciMatic Manuscript Manager atau Thesis Manager
Penulis Nucci M;Landau M;Silveira F;Spector N;Pulcheri W;;
Jurnal Infection control and hospital epidemiology
Tahun 2001
DOI
DOI tidak ditemukan
URL
http://www.ncbi.nlm.nih.gov/pubmed/11776354
Kata Kunci
National Center for Biotechnology Information NCBI NLM MEDLINE Teaching humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female male adolescent aged middle aged Child hospitals drug therapy fever / drug therapy* neutropenia / drug therapy* anti-bacterial agents / therapeutic use* combination / therapeutic use* fever / complications neutropenia / complications brazil vancomycin / therapeutic use practice guidelines as topic* cefepime cephalosporins / administration & dosage ceftazidime / therapeutic use pmid:11776354 doi:10.1086/501839 m nucci m landau w pulcheri amikacin / therapeutic use oxacillin / administration & dosage teicoplanin / therapeutic use

Sitasi

Tidak ada sitasi yang ditemukan. Untuk menambahkan sitasi, hubungi admin di info@scimatic.org

Komentar

Belum ada komentar. Jadilah yang pertama berkomentar pada artikel ini.